Yesse Technologies secures another grant from The Michael J. Fox Foundation to sniff out Parkinson’s disease
The Pharma Data
JANUARY 18, 2021
Yesse Technologies’ core technology, the ORion21 genetic platform, is the product of over 30 years of fundamental research on the molecular biology of the sense of smell and is exclusively licensed from The City University of New York. This mission is at the core of the Center of Expertise as well. Source link.
Let's personalize your content